EMEA-002259-PIP01-17
Key facts
Active substance |
Levothyroxine (sodium)
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0096/2018
|
PIP number |
EMEA-002259-PIP01-17
|
Pharmaceutical form(s) |
Oral solution
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
IBSA Institut Biochimique SA
Tel. +41 5836 01718 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|